Brief: Bellerophon Therapeutics Appointed Peter Fernandes As Interim Principal Executive Officer
12/11/2021 13:29
Nov 12 (Reuters) - Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON THERAPEUTICS INC - ON NOV 11, BOARD APPOINTED
PETER
FERNANDES TO SERVE AS INTERIM PRINCIPAL EXECUTIVE OFFICER
EFFECTIVE NOVEMBER 11, 2021
* BELLEROPHON THERAPEUTICS INC - FERNANDES CURRENTLY SERVES
AS
CO'S CHIEF REGULATORY & SAFETY OFFICER, WILL ADDITIONALLY
CONTINUE IN THAT ROLE
Source text: [https://bit.ly/3kw7ydM]
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen